Janus Henderson Group PLC Alaunos Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $17,821 - $53,899	-43,467 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $6 - $11	10 Added 0.02%	43,467 $28,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $23,807 - $41,281	21,842 Added 101.05%	43,457 $48,000
Q3 2021 Nov 16, 2021	BUY	$1.44 - $2.73 $31,125 - $59,008	21,615 New	21,615 $39,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.